PRJ-780-NELCSU-QAdmissions for NEL customers

We currently have a requirement for the provision of a clinical risk prediction tool to underpin our current risk stratification services for North West London CCGs. The details of which are set out in the Annex A to this RFQ letter. We require the preferred supplier to commence providing the service on 25 March 2019 and for an initial period of 12 months ("the Initial Term") unless earlier terminated in accordance with Clause 2.1. The Initial Term shall be followed by an optional extension period of 12 months. The...